Hemostasis/Coagulation Analyzer Market

Hemostasis/Coagulation Analyzer Market by Product (Clinical Laboratory & PoCT Analyzers), Consumables, Test (PT, Fibrinogen, APTT, ACT, D Dimer, Platelet Function), Technology (Mechanical, Optical, Electrochemical), End User (PoCT) - Forecast to 2021

Report Code: MD 3255 Nov, 2016, by marketsandmarkets.com

The coagulation analyzers market is projected to reach USD 4.84 billion by 2021 from USD 2.98 billion in 2016, at a CAGR of 10.2% from 2016 to 2021. The high incidence and large economic burden of blood related diseases and CVD’s, rise in healthcare spending has resulted in the increasing use of coagulation analyzers market products. Moreover, high growth potential in the Asian region provides growth opportunities to players in the coagulation analyzers market. On the other hand, stringent regulatory policies for validation of medical devices creates an obstacle for entry of small players, are the major factors restraining the growth of this market. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.

Market Dynamics

Drivers

  • Increasing Prevalence of Cardiovascular Diseases and Blood Disorders
  • Rising Aging Population
  • Development of High-Sensitivity POC Coagulation Testing
  • Increasing Laboratory Automation

Restraint

  • High Cost of Fully Automated Coagulation Analyzer

Opportunities

  • Emerging Markets

Challenges

  • Slow Adoption of Advanced Hemostasis Instruments in Emerging Economies

The objectives of this study are as follows:

  • To define, describe, and forecast the global coagulation analyzers market by product, test type, technology, patient care setting and region
  • To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities and challenges)
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
  • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  •  To track and analyze competitive developments such as product launches, agreements, expansions, acquisitions, and other developments in the global coagulation analyzers market.

Research Methodology

Top-down and bottom-up approaches were used to estimate and validate the size of the global coagulation analyzers market and to estimate the size of various other dependent submarkets. The overall market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation—by products, test type, technology and region) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.

Various secondary sources referred to for this research study include publications from government sources such as the white papers; articles from recognized authors; gold standard and silver standard websites, directories, and databases; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations have been used to identify and collect information useful for this extensive commercial study of the coagulation analyzers market. Primary sources such as experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess prospects of the coagulation analyzers market. The breakdown of profiles of primaries is shown in the figure below:

Coagulation/Hemostasis Analyzer Market

To know about the assumptions considered for the study, download the pdf brochure

The major players in the coagulation analyzers market are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), and International Technidyne Corporation (U.S.).

Target Audience for this Report:

  • Coagulation Analyzer and Consumable Manufacturers And Suppliers
  • Clinical Laboratories
  • Hospitals
  • Pharmaceutical and biotechnology companies
  • Academic research institutes related to coagulation testing market
  • Venture Capitalists

Value Addition for the Buyer:

This report provides insights into the global coagulation analyzers market. It provides valuable information on the products, tests, and regions in the coagulation analyzers market. The geographic analysis for these segments is also presented in this report. Leading players in the market are profiled to study their device offerings and understand strategies undertaken by them to be competitive in this market.

The above-mentioned information would help the buyer understand market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize on the growth opportunities.

Major Market Developments

  • In 2016, Nihon Kohden expanded U.S. operations in New Pennsylvania facility. This facility will provide response to customers across all U.S. time zones, especially to major institutions in and around the East Coast.
  • In 2016, Roche launched Accu-Chek Guide blood glucose monitoring system, which makes every step of testing easy to simplify everyday diabetes routines.
  • In 2016, Siemens launched Sysmex CS-2500 System, a new mid-volume coagulation analyzer and celebrates expanded portfolio.

Critical questions the report answers

  • How the market developments of key players impact the overall industry?
  • What are the restraining factors for this market?

High Cost of Fully Automated Coagulation Analysers Will Restrain the Growth of Market

Implementation of coagulation analyzers in diagnostic laboratories requires high capital investments. In developing countries such as India, China, and Brazil, owing to budget constraints, small- and medium-sized hospitals and diagnostic laboratories cannot afford high priced, fully automated, technologically advanced coagulation analyzers. The cost of coagulation analyzers varies between USD 8,600 and USD 190,000 (Source: CAP TODAY, January 2015). Thus, hospitals and diagnostic laboratories that do not require regular coagulation testing are reluctant towards the implementation of fully automated coagulation analyzers. This results in a low adoption of these instruments in a large number of end users. Hence, the high cost of coagulation analyzers is considered as one of the key factors restraining the growth of this market.

Scope of the Report:

This report categorizes the coagulation analyzers market into the following segments:

Coagulation Analyzer Market, by Product

  • Clinical Laboratory Analyzers
    • Systems
      • Automated Systems
      • Semi-automated Systems
      • Manual Systems
    • Consumables
      • Reagents
      • Standards, Controls and Calibrations
  • Analyzers for Point-of-Care Testing

Coagulation Analyzer Market, By Test

  • Prothrombin Time
  • Fibrinogen
  • Activated Partial Thromboplastin Time
  • Activated Clotting Time
  • D Dimer
  • Platelet Function
  • Anti-factor Xa
  • Heparin & Protamine Dose Response Test for ACT
  • Other Coagulation Tests

Coagulation Analyzer Market, By Technology

  • Mechanical
  • Optical
  • Electrochemical
  • Other Technologies

Coagulation Analyzer Market, By End Users

  • Clinical Laboratories
  • POC
  • Others End Users

Coagulation Analyzer Market by Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia
    • China
    • Japan
    • India
    • RoA
  • Rest of the World (RoW)

Customization Options:

  • Company Information: Detailed company profiles of five or more market players
  • Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market.

The coagulation analyzers market is projected to reach USD 4.84 billion by 2021 from USD 2.98 billion in 2016, at a CAGR of 10.2% from 2016 to 2021. The high incidence and large economic burden of blood related diseases and CVD’s, rise in healthcare spending has resulted in the increasing use of coagulation analyzers market products. Moreover, high growth potential in the Asian region provides growth opportunities to players in the coagulation analyzers market. On the other hand, stringent regulatory policies for validation of medical devices creates an obstacle for entry of small players, are the major factors restraining the growth of this market.

This market is segmented based on product, test, technology, end-users, and regions. The coagulation analyzers market consists of various products that are used by clinical laboratories, hospitals, patient self-testing and others. On the basis of product, coagulation analyzers market is segmented into clinical laboratory analyzers and PoC testing analyzers. The clinical laboratory analyzers segment is expected to account for the largest share of the global coagulation analyzers market in 2016. Owing to increasing rental agreements, the consumables market is expected to grow in the coming years.

Based on test, the coagulation analyzers market is segmented into nine major test segments, namely, prothrombin time testing, fibrinogen testing, ACT, APTT, d dimer testing, platelet function test, anti-factor Xa test, heparin & protamine dose response test for ACT and other coagulation tests. The prothrombin time testing is the largest growing test segment of this market, and the ACT test is segment is expected to grow at a faster rate in forecasted period.

Coagulation/Hemostasis Analyzer Market

The global coagulation analyzers market is dominated by North America, followed by Europe, Asia, and the Rest of the World. North America will continue to dominate the global coagulation analyzers market in the forecast period. However, Asia is expected to witness the highest CAGR, with the growth in this market centred at China, Japan and India.

Development Of High-Sensitivity PoC Coagulation Testing Will Boost the Growth of This Market

Currently, point-of-care (PoC) devices are available in the market and provide rapid bedside monitoring to aid clinicians in directing appropriate targeted therapy. Majority of POC devices used today can perform multiple coagulation tests and provide high sensitivity, improved patient compliance, and decreased testing turnaround time (compared to laboratory testing coagulation analyzers) for the diagnosis and management of blood disorders. Consequently, the demand for POC testing coagulation analyzers is increasing across the globe.

Due to technological advancements, dual- and four-channel systems that can be simultaneously used for testing of PT, APTT, ACT, and fibrinogen testing, have been launched in the market. Moreover, technological advancements in point-of-care procedures along with quality assurance and home testing services are anticipated to gear up the market growth over the forecast period. Driven by the increasing demand for PoC testing, several players are focusing on the development of PoC coagulation analyzers.

Key players in the single-cell analysis market are Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), and International Technidyne Corporation (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology (Page No. - 21)
    2.1 Secondary Data
           2.1.1 Key Data From Secondary Sources
    2.2 Primary Data
           2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 29)
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 34)
    4.1 Coagulation Analyzer Market Overview

5 Market Overview (Page No. - 37)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Prevalence of Cardiovascular Diseases and Blood Disorders
                    5.2.1.2 Rising Aging Population
                    5.2.1.3 Development of High-Sensitivity POC Coagulation Testing
                    5.2.1.4 Increasing Laboratory Automation
           5.2.2 Restraint
                    5.2.2.1 High Cost of Fully Automated Coagulation Analyzer
           5.2.3 Opportunity
                    5.2.3.1 Emerging Markets
           5.2.4 Challenge
                    5.2.4.1 Slow Adoption of Advanced Hemostasis Instruments in Emerging Economies

6 Coagulation Analyzer Market, By Product (Page No. - 44)
    6.1 Introduction
    6.2 Clinical Laboratory Analyzers
           6.2.1 Consumables
                    6.2.1.1 Reagents
                    6.2.1.2 Standards, Controls, and Calibrations
           6.2.2 Systems
                    6.2.2.1 Automated Systems
                    6.2.2.2 Semiautomated Systems
                    6.2.2.3 Manual Systems
    6.3 Point-Of-Care Testing Analyzers

7 Coagulation Analyzer Market, By Test (Page No. - 58)
    7.1 Introduction
    7.2 Prothrombin Time Testing
    7.3 Fibrinogen Testing
    7.4 Activated Clotting Time Testing
    7.5 Activated Partial Thromboplastin Time Testing
    7.6 D-Dimer Testing
    7.7 Platelet Function Tests
    7.8 Anti-Factor Xa Tests
    7.9 Heparin & Protamine Dose Response Tests for ACT
    7.10 Other Coagulation Tests

8 Coagulation Analyzer Market, By Technology (Page No. - 70)
    8.1 Introduction
    8.2 Optical Technology
    8.3 Mechanical Technology
    8.4 Electrochemical Technology
    8.5 Other Technologies

9 Coagulation Analyzer Market, By Patient Care Setting (Page No. - 76)
    9.1 Introduction
    9.2 Clinical Laboratories
    9.3 Point-Of-Care Testing
    9.4 Other End Users

10 Coagulation Analyzer Market, By Region (Page No. - 81)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 U.K.
             10.3.3 France
             10.3.4 Italy
             10.3.5 Spain
             10.3.6 Rest of Europe (RoE)
     10.4 Asia
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 Rest of Asia (RoA)
     10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. - 131)
     11.1 Introduction
     11.2 Strategic Overview
     11.3 Market Share Analysis
     11.4 Competitive Situation and Trends
             11.4.1 Product Launches
             11.4.2 Expansions
             11.4.3 Agreements
             11.4.4 Other Developments

12 Company Profiles (Page No. - 138)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Introduction
     12.2 Alere Inc.
     12.3 Nihon Kohden Corporation
     12.4 Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
     12.5 Siemens Healthcare (A Division of Siemens AG)
     12.6 Sysmex Corporation
     12.7 Thermo Fisher Scientific Inc.
     12.8 Diagnostica Stago Sas
     12.9 Helena Laboratories
     12.10 Instrumentation Laboratory (A Division of the Werfen Group)
     12.11 International Technidyne Corporation (ITC)

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 158)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


List of Tables (96 Tables)

Table 1 Examples of POC Coagulation Analyzer By Leading Players
Table 2 Coagulation Analyzer Market Size, By Product, 2014–2021 (USD Million)
Table 3 Clinical Laboratory Analyzers Market Size, By Type, 2014–2021 (USD Million)
Table 4 Clinical Laboratory Analyzers Market Size, By Region, 2014–2021 (USD Million)
Table 5 Clinical Laboratory Analyzers Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 6 Clinical Laboratory Analyzers Market Size for Consumables, By Region, 2014–2021 (USD Million)
Table 7 Consumables Market Size for Reagents, By Region, 2014–2021 (USD Million)
Table 8 Consumables Market Size for Standards, Controls, and Calibrations, By Region, 2014–2021 (USD Million)
Table 9 Clinical Laboratory Analyzers Market Size for Systems, By Type, 2014–2021 (USD Million)
Table 10 Clinical Laboratory Analyzers Market Size for Systems, By Region, 2014–2021 (USD Million)
Table 11 Automated Systems Market Size, By Region, 2014–2021 (USD Million)
Table 12 Semiautomated Systems Market Size, By Region, 2014–2021 (USD Million)
Table 13 Manual Systems Market Size, By Region, 2014–2021 (USD Million)
Table 14 POC Testing Analyzers Market Size, By Region, 2014–2021 (USD Million)
Table 15 Coagulation Analyzer Market Size, By Test, 2014–2021 (USD Million)
Table 16 Prothrombin Time Testing Market Size, By Region, 2014–2021 (USD Million)
Table 17 Fibrinogen Testing Market Size, By Region, 2014–2021 (USD Million)
Table 18 ACT Testing Market Size, By Region, 2014–2021 (USD Million)
Table 19 APTT Testing Market Size, By Region, 2014–2021 (USD Million)
Table 20 D-Dimer Testing Market Size, By Region, 2014–2021 (USD Million)
Table 21 Platelet Function Tests Market Size, By Region, 2014–2021 (USD Million)
Table 22 Anti-Factor Xa Tests Market Size, By Region, 2014–2021 (USD Million)
Table 23 Heparin & Protamine Dose Response Tests for ACT Market Size, By Region, 2014–2021 (USD Million)
Table 24 Other Coagulation Tests Market Size, By Region, 2014–2021 (USD Million)
Table 25 Coagulation Analyzer Market Size, By Technology, 2014–2021 (USD Million)
Table 26 Optical Technology Market Size, By Region, 2014–2021 (USD Million)
Table 27 Mechanical Technology Market Size, By Region, 2014–2021 (USD Million)
Table 28 Electrochemical Technology Market Size, By Region, 2014–2021 (USD Million)
Table 29 Other Technologies Market Size, By Region, 2014–2021 (USD Million)
Table 30 Market Size, By End User, 2014–2021 (USD Million)
Table 31 Clinical Laboratories Market Size, By Region, 2014–2021 (USD Million)
Table 32 Point-Of-Care Testing Market Size, By Region, 2014–2021 (USD Million)
Table 33 Other End Users Market Size, By Region, 2014–2021 (USD Million)
Table 34 Market Size, By Region, 2014–2021 (USD Million)
Table 35 List of Related Conferences Held in North America
Table 36 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 37 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 38 North America: Market Size, By Technology, 2014–2021 (USD Million)
Table 39 North America: Market Size, By Test, 2014–2021 (USD Million)
Table 40 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 41 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 42 U.S.: Market Size, By Test, 2014–2021 (USD Million)
Table 43 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 44 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 45 Canada: Market Size, By Test, 2014–2021 (USD Million)
Table 46 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 47 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 48 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 49 Europe: Market Size, By Technology, 2014–2021 (USD Million)
Table 50 Europe: Market Size, By Test, 2014–2021 (USD Million)
Table 51 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 52 Germany: Market Size, By Product, 2014–2021 (USD Million)
Table 53 Germany: Market Size, By Test, 2014–2021 (USD Million)
Table 54 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 55 U.K.: Market Size, By Product, 2014–2021 (USD Million)
Table 56 U.K.: Market Size, By Test, 2014–2021 (USD Million)
Table 57 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 58 France: Market Size, By Product, 2014–2021 (USD Million)
Table 59 France: Market Size, By Test, 2014–2021 (USD Million)
Table 60 France: Market Size, By End User, 2014–2021 (USD Million)
Table 61 Italy: Market Size, By Product, 2014–2021 (USD Million)
Table 62 Italy: Market Size, By Test, 2014–2021 (USD Million)
Table 63 Italy: Market Size, By End User, 2014–2021 (USD Million)
Table 64 Spain: Market Size, By Product, 2014–2021 (USD Million)
Table 65 Spain: Hemostasis Analyzer Market Size, By Test, 2014–2021 (USD Million)
Table 66 Spain: Hemostasis Analyzer Market Size, By End User, 2014–2021 (USD Million)
Table 67 RoE: Hemostasis Analyzer Market Size, By Product, 2014–2021 (USD Million)
Table 68 RoE: Hemostasis Analyzer Market Size, By Test, 2014–2021 (USD Million)
Table 69 RoE: Hemostasis Analyzer Market Size, By End User, 2014–2021 (USD Million)
Table 70 Asia: Hemostasis Analyzer Market Size, By Country, 2014–2021 (USD Million)
Table 71 Asia: Hemostasis Analyzer Market Size, By Product, 2014–2021 (USD Million)
Table 72 Asia: Hemostasis Analyzer Market Size, By Technology, 2014–2021 (USD Million)
Table 73 Asia: Hemostasis Analyzer Market Size, By Test, 2014–2021 (USD Million)
Table 74 Asia: Hemostasis Analyzer Market Size, By End User, 2014–2021 (USD Million)
Table 75 China: Hemostasis Analyzer Market Size, By Product, 2014–2021 (USD Million)
Table 76 China: Hemostasis Analyzer Market Size, By Test, 2014–2021 (USD Million)
Table 77 China: Hemostasis Analyzer Market Size, By End User, 2014–2021 (USD Million)
Table 78 Japan: Coagulation Analyzer Market Size, By Product, 2014–2021 (USD Million)
Table 79 Japan: Coagulation Analyzer Market Size, By Test, 2014–2021 (USD Million)
Table 80 Japan: Coagulation Analyzer Market Size, By End User, 2014–2021 (USD Million)
Table 81 India: Coagulation Analyzer Market Size, By Product, 2014–2021 (USD Million)
Table 82 India: Coagulation Analyzer Market Size, By Test, 2014–2021 (USD Million)
Table 83 India: Coagulation Analyzer Market Size, By End User, 2014–2021 (USD Million)
Table 84 RoA: Coagulation Analyzer Market Size, By Product, 2014–2021 (USD Million)
Table 85 RoA: Coagulation Analyzer Market Size, By Test, 2014–2021 (USD Million)
Table 86 RoA: Coagulation Analyzer Market Size, By End User, 2014–2021 (USD Million)
Table 87 RoW: Coagulation Analyzer Market Size, By Region, 2014–2021 (USD Million)
Table 88 RoW: Coagulation Analyzer Market Size, By Product, 2014–2021 (USD Million)
Table 89 RoW: Coagulation Analyzer Market Size, By Technology, 2014–2021 (USD Million)
Table 90 RoW: Coagulation Analyzer Market Size, By Test, 2014–2021 (USD Million)
Table 91 RoW: Coagulation Analyzer Market Size, By End User, 2014–2021 (USD Million)
Table 92 Growth Strategy Matrix, 2014–2016
Table 93 Product Launches, 2014–2016
Table 94 Expansions, 2014–2016
Table 95 Agreements, 2014–2016
Table 96 Other Developments, 2014–2016


List of Figures (57 Figures)

Figure 1 Global Coagulation Analyzer Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation and Region
Figure 4 Coagulation Analyzer Market: Bottom-Up Approach
Figure 5 Coagulation Analyzer Market: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global Coagulation Analyzer Market Size, By Product, 2016 vs 2021 (USD Billion)
Figure 8 Global Coagulation Analyzer Market Size, By Test, 2016 vs 2021 (USD Billion)
Figure 9 Global Coagulation Analyzer Market Size, By Technology, 2016 vs 2021 (USD Billion)
Figure 10 Global Coagulation Analyzer Market Size, By End User, 2016 vs 2021 (USD Billion)
Figure 11 Global Coagulation Analyzer Market Size, By Region
Figure 12 Global Coagulation Analyzer Market to Witness Moderate Growth During the Forecast Period
Figure 13 Optical Technology Segment to Dominate the Global Coagulation Analyzer Market in 2016
Figure 14 Asian Market to Witness the Highest Growth During the Forecast Period
Figure 15 Coagulation Analyzer Market: Drivers, Restraints, Opportunities & Challenges
Figure 16 Coagulation Analyzer Market Segmentation, By Product
Figure 17 Clinical Laboratory Analyzers Will Continue to Dominate the Coagulation Analyzer Market During the Forecast Period
Figure 18 Consumables Will Continue to Dominate the Clinical Laboratory Analyzers Market During the Forecast Period
Figure 19 Reagents Will Continue to Dominate the Consumables Market During the Forecast Period
Figure 20 Automated Systems Will Continue to Dominate the Coagulation Systems Market During the Forecast Period
Figure 21 Prothrombin Time Testing Segment Will Continue to Dominate the Coagulation Analyzer Market During the Forecast Period
Figure 22 North America to Command the Largest Share of the Prothrombin Time Testing Market in 2016
Figure 23 Optical Technology to Dominate the Coagulation Analyzer Market During the Forecast Period
Figure 24 Clinical Laboratories Segment Will Continue to Dominate the Coagulation Analyzer Market During the Forecast Period
Figure 25 North America to Dominate the Global Coagulation Analyzer Market in 2016
Figure 26 The Coagulation Analyzer Market in Asia is Expected to Grow at the Highest Rate During the Forecast Period
Figure 27 North America: Coagulation Analyzer Market Snapshot
Figure 28 The U.S. is Estimated to Dominate the North American Coagulation Analyzer Market in 2016
Figure 29 Clinical Laboratory Analyzers are Estimated to Be the Largest Product Segment in the North American Coagulation Analyzer Market in 2016
Figure 30 Clinical Laboratory Analyzers are Estimated to Be the Largest Product Segment in the U.S. Coagulation Analyzer Market in 2016
Figure 31 Clinical Laboratory Analyzers are Expected to Dominate the Coagulation Analyzer Market in Canada During the Forecast Period
Figure 32 Germany is Estimated to Dominate the European Coagulation Analyzer Market in 2016
Figure 33 POC Testing Analyzers to Register Highest Growth in the Coagulation Analyzer Market During the Forecast Period
Figure 34 Clinical Laboratory Analyzers are Estimated to Be the Largest Product Segment in the Coagulation Analyzer Market in Germany in 2016
Figure 35 Clinical Laboratory Analyzers to Command the Coagulation Analyzer Products Market in the U.K. in 2016
Figure 36 Clinical Laboratory Analyzers Estimated to Dominate the French Market in 2016
Figure 37 Clinical Laboratory Analyzers Estimated to Be the Largest Product Segment in the Italian Coagulation Analyzer Market in 2016
Figure 38 Coagulation Analyzer for POC Testing Segment to Grow at the Highest Rate in the Spanish Market
Figure 39 Clinical Laboratory Analyzers to Hold Largest Share in RoE in 2016
Figure 40 Asia: Coagulation Analyzer Market Snapshot
Figure 41 China is Estimated to Dominate the Asian Coagulation Analyzer Market in 2016
Figure 42 Clinical Laboratory Analyzers to Be the Largest Product Segment in Asian Market in 2016
Figure 43 Clinical Laboratory Analyzers to Be the Largest Product Segment in the Chinese Coagulation Analyzer Market in 2016
Figure 44 Clinical Laboratory Analyzers to Hold Largest Share in Japanese Market in 2016
Figure 45 POC Testing Analyzers to Witness Highest Growth in the Indian Market During the Forecast Period
Figure 46 Clinical Laboratory Analyzers, the Major Product Segment in RoA in 2016
Figure 47 South America, Central America, and the Caribbean to Dominate the RoW Coagulation Analyzer Market in 2016
Figure 48 Clinical Laboratory Analyzers Expected to Dominate the RoW Market, By Product, in 2016
Figure 49 Product Launch Was the Key Growth Strategy Adopted By Players in the Coagulation Analyzer Market
Figure 50 Coagulation Analyzer Market Share Analysis, By Key Player, 2015
Figure 51 Geographic Revenue Mix of the Top 5 Market Players
Figure 52 Company Snapshot: Alere Inc.
Figure 53 Company Snapshot: Nihon Kohden Corporation
Figure 54 Company Snapshot: Roche Diagnostics
Figure 55 Company Snapshot: Siemens AG
Figure 56 Company Snapshot: Sysmex Corporation
Figure 57 Company Snapshot: Thermo Fisher Scientific Inc.


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 3255
Published ON
Nov, 2016
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Hemostasis/Coagulation Analyzer Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved